HRPAP20: a novel calmodulin-binding protein that increases breast cancer cell invasion
- 25 September 2006
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 26 (12), 1780-1788
- https://doi.org/10.1038/sj.onc.1209980
Abstract
We previously reported the identification of HRPAP20 (hormone-regulated proliferation-associated protein 20), a novel hormone-regulated, proliferation-associated protein. In tumor cell lines, constitutive HRPAP20 expression enhanced proliferation and suppressed apoptosis, characteristics frequently associated with malignant progression. Here, we report that highly invasive breast cancer cell lines and human breast tumor specimens express elevated HRPAP20, which in transfection experiments in MCF-7 and MDA-MB-231 cells, increased invasion. Results from mechanistic studies revealed that HRPAP20 bound to calmodulin (CaM) via a conserved CaM-binding motif. Transfection of MCF-7 breast cancer cells with HRPAP20 harboring a mutated CaM-binding motif (HRPAP20K73A) inhibited its interaction with CaM and failed to increase invasion. Other experiments revealed that transfection with HRPAP20, but not HRPAP20K73A, increased secretion of matrix metalloproteinase-9 (MMP-9). Moreover, knockdown of HRPAP20 with small interfering RNA in MCF-7/HRPAP20 transfectants and wild-type MDA-MB-231 cells reduced invasion and inhibited secretion of MMP-9. Together these observations suggest that HRPAP20 may be an important regulator of breast tumor cell invasion by a CaM-mediated mechanism that leads to increased MMP-9 secretion. We conclude that dysregulation of HRPAP20 expression in tumor cells may contribute to the observed phenotypic changes associated with breast cancer progression.Keywords
This publication has 34 references indexed in Scilit:
- The Matrix Metalloproteinase-9/Neutrophil Gelatinase-Associated Lipocalin Complex Plays a Role in Breast Tumor Growth and Is Present in the Urine of Breast Cancer PatientsClinical Cancer Research, 2005
- Understanding breast cancer risk - where do we stand in 2005?Journal of Cellular and Molecular Medicine, 2005
- Heme Oxygenase-2 Is Activated by Calcium-CalmodulinPublished by Elsevier BV ,2004
- Matrix metalloproteinase expression in breast cancerJournal of Surgical Research, 2003
- Breast Cancer Gene Expression AnalysisPublished by Springer Science and Business Media LLC ,2003
- Modulation of the Ras/Raf/MEK/ERK pathway by Ca2+, and CalmodulinCellular Signalling, 2002
- Proteolysis in human breast cancerMolecular Pathology, 2000
- Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanismsCancer Letters, 1997
- Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Molecular and Structural Basis of Target Recognition by CalmodulinAnnual Review of Biophysics and Biophysical Chemistry, 1995